Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-2025154175-A1 · May 15, 2025 · US
This page is not indexed by search engines while we improve data quality.
Rosenstein Björn patents
Rosenstein Björn is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rosenstein Björn |
| Total patents | 15 |
| First publication | Dec 27, 2018 |
| Latest publication | May 15, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-12180227-B2 · Dec 31, 2024 · US
Substituted diazahetero-bicyclic compounds and their use
US-2022259228-A1 · Aug 18, 2022 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-2022017540-A1 · Jan 20, 2022 · US
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors
US-11208422-B2 · Dec 28, 2021 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-11098063-B2 · Aug 24, 2021 · US
Substituted diazahetero-bicyclic compounds and their use
US-2021024545-A1 · Jan 28, 2021 · US
2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
US-10759794-B2 · Sep 1, 2020 · US
Substituted bridged diazepane derivatives and use thereof as task-1 and task-3 inhibitors
US-2020140461-A1 · May 7, 2020 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-2020109155-A1 · Apr 9, 2020 · US
Recent patents
Latest publications not already listed above.
Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy
US-2020093737-A1 · Mar 26, 2020 · US
Pharmaceutical dosage forms containing task-i and task-3 channel inhibitors, and the use of same in breathing disorder therapy
US-2020085734-A1 · Mar 19, 2020 · US
Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same
US-10414765-B2 · Sep 17, 2019 · US
2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
US-2019062326-A1 · Feb 28, 2019 · US
Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same
US-2018370965-A1 · Dec 27, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 15 |
| Bayer Ag | 8 |
| Bayer Ag | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P11/00 | 15 |
| A61P25/00 | 11 |
| C07D519/00 | 11 |
| A61K45/06 | 8 |
| A61K31/5386 | 7 |